Variant · Snv
VHL G114V (c.341G>T)
CI-VAR-00001578Explore in graph →NP_000542.1:p.Gly114ValNM_000551.4:c.341G>TCIViC 2491
Curated evidence
Evidence by cancer (1 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
- Source
- CIViC — Clinical Interpretation of Variants in Cancer
- Dataset
- CIViC evidence items
- Version
- civic-2026-09-08
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- expert curation
- License
- CC0 1.0
- PMID
- 24335534
- Run
- ING-CIVIC-20260908-000001
| Molecular profile | Therapy | Type | Level | Direction · significance | Rating (1–5) | Status | Evidence | Source |
|---|---|---|---|---|---|---|---|---|
| Von Hippel-Lindau Disease1unmapped disease | ||||||||
| VHL G114V (c.341G>T) | (predisposing) | Predisposing | C | Supports Uncertain Significance | 3 | submitted | EID6730Tissues from 23 CNS hemangioblastoma patients were analyzed. 8 patients had germline VHL mutations. One patient with a germline missense mutation (c.341G>T; p.Gly114Val) in the VHL gene was diagnosed … (full text at CIViC) PMID 24335534 · Muscarella et al., 2014 · Open in CIViC | civic |
ClinVar
Clinical significance (0)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
Data not yet available